ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions

ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions

SAN DIEGO, May 25, 2018 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced an oral presentation at the American Diabetes Association’s (ADA) 78th Scientific Sessions.  ViaCyte is developing novel stem cell-derived islet replacement therapies that could transform the way that patients